EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pushing the Survival Bar Higher: Two Decades of Innovation in Lung Transplantation

Khalil Aburahma, Nunzio Davide de Manna iD, Christian Kuehn, Jawad Salman, Mark Greer, Fabio Ius

Journal of Clinical Medicine · 18.09.2024 · 13 (18) · 5516

DOI: 10.3390/jcm13185516 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.09.2024. Verfasst von Khalil Aburahma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, 30625 Hannover, Germany. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 231 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Survival after lung transplantation has significantly improved during the last two decades. The refinement of the already existing extracorporeal life support (ECLS) systems, such as extracorporeal membrane oxygenation (ECMO), and the introduction of new techniques for donor lung optimization, such as ex vivo lung perfusion (EVLP), have allowed the extension of transplant indication to patients with end-stage lung failure after acute respiratory distress syndrome (ARDS) and the expansion of the donor organ pool, due to the better evaluation and optimization of extended-criteria donor (ECD) lungs and of donors after circulatory death (DCD). The close monitoring of anti-HLA donor-specific antibodies (DSAs) has allowed the early recognition of pulmonary antibody-mediated rejection (AMR), which requires a completely different treatment and has a worse prognosis than acute cellular rejection (ACR). As such, the standardization of patient selection and post-transplant management has significantly contributed to this positive trend, especially at high-volume centers. This review focuses on lung transplantation after ARDS, on the role of EVLP in lung donor expansion, on ECMO as a principal cardiopulmonary support system in lung transplantation, and on the diagnosis and therapy of pulmonary AMR.

Schlagwörter

Stichwörter der Autor:innen

acute respiratory distress syndromeantibody-mediated rejectionex-vivo lung perfusionextracorporeal membrane oxygenationlung transplantationsurvival

Autor:innen und Institutionen

  • Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, 30625 Hannover, Germany.
  • German Centre for Lung Research (DZL/BREATH), 35392 Hannover, Germany.
  • Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, 30625 Hannover, Germany.

ORCID-Profile: Nunzio Davide de Manna

Zitieren

APA

Aburahma, K., de Manna, N. D., Kuehn, C., Salman, J., Greer, M., & Ius, F. (2024). Pushing the Survival Bar Higher: Two Decades of Innovation in Lung Transplantation. Journal of Clinical Medicine, 13(18), 5516. https://doi.org/10.3390/jcm13185516

Vancouver

Aburahma K, de Manna ND, Kuehn C, Salman J, Greer M, Ius F. Pushing the Survival Bar Higher: Two Decades of Innovation in Lung Transplantation. Journal of Clinical Medicine. 2024;13(18):5516. doi:10.3390/jcm13185516

BibTeX
@article{Aburahma2024,
  author = {Aburahma, Khalil and de Manna, Nunzio Davide and Kuehn, Christian and Salman, Jawad and Greer, Mark and Ius, Fabio},
  title = {Pushing the Survival Bar Higher: Two Decades of Innovation in Lung Transplantation},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {18},
  pages = {5516},
  doi = {10.3390/jcm13185516}
}
Kostenlos starten →